Pseudocarcinomatous Hyperplasia Masquerading as a Well-Differentiated Squamous Cell Carcinoma Associated With Primary Cutaneous Anaplastic Large-Cell Lymphoma.
Donn LaTourMichael P LeeJeffrey T GardnerHarry DaoJustin KerstetterAshley ElsensohnPublished in: The American Journal of dermatopathology (2022)
Pseudocarcinomatous hyperplasia (PCH) is a reactive proliferation of the epidermis associated with CD30 + lymphoproliferative disorders. In this article, we report the case of a 42-year-old man who presented with a 10-year history of a solitary erythematous patch on the right thigh that progressed to an ulcerated, crusted plaque. Histologic examination revealed an infiltrate of atypical CD30 + lymphocytes consistent with primary cutaneous anaplastic large-cell lymphoma with overlying well differentiated keratinocyte hyperplasia akin to a well-differentiated invasive squamous cell carcinoma. This case demonstrates the phenomenon of pseudocarcinomatous hyperplasia mimicking features of invasive squamous cell carcinoma. It highlights the necessity of careful clinical correlation when diagnosing squamous cell carcinomas in younger patients on non-sun-exposed areas and the exclusion of accompanying known causes of pseudocarcinomatous hyperplasia.
Keyphrases
- squamous cell carcinoma
- single cell
- squamous cell
- diffuse large b cell lymphoma
- end stage renal disease
- cell therapy
- lymph node metastasis
- locally advanced
- ejection fraction
- newly diagnosed
- epstein barr virus
- prognostic factors
- coronary artery disease
- radiation therapy
- peritoneal dialysis
- high grade
- patient reported outcomes
- mesenchymal stem cells
- soft tissue